Literature DB >> 23803412

Ganoderma lucidum stimulates NK cell cytotoxicity by inducing NKG2D/NCR activation and secretion of perforin and granulysin.

Chih-Jung Chang1, Yi-Yuan M Chen, Chia-Chen Lu, Chuan-Sheng Lin, Jan Martel, Sheng-Hui Tsai, Yun-Fei Ko, Tsung-Teng Huang, David M Ojcius, John D Young, Hsin-Chih Lai.   

Abstract

Ganoderma lucidum (G. lucidum) is a medicinal mushroom long used in Asia as a folk remedy to promote health and longevity. Recent studies indicate that G. lucidum activates NK cells, but the molecular mechanism underlying this effect has not been studied so far. To address this question, we prepared a water extract of G. lucidum and examined its effect on NK cells. We observed that G. lucidum treatment increases NK cell cytotoxicity by stimulating secretion of perforin and granulysin. The mechanism of activation involves an increased expression of NKG2D and natural cytotoxicity receptors (NCRs), as well as increased phosphorylation of intracellular MAPKs. Our results indicate that G. lucidum induces NK cell cytotoxicity against various cancer cell lines by activating NKG2D/NCR receptors and MAPK signaling pathways, which together culminate in exocytosis of perforin and granulysin. These observations provide a cellular and molecular mechanism to account for the reported anticancer effects of G. lucidum extracts in humans.

Entities:  

Keywords:  Ganoderma lucidum; NCR; NK cell; NKG2D; granulysin; perforin

Mesh:

Substances:

Year:  2013        PMID: 23803412     DOI: 10.1177/1753425913491789

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  8 in total

1.  Structure and bioactivities of a polysaccharide isolated from Ganoderma lucidum in submerged fermentation.

Authors:  Aisikaer Ai-Lati; Shuangping Liu; Zhongwei Ji; Hao Zhang; Jian Mao
Journal:  Bioengineered       Date:  2017-01-31       Impact factor: 3.269

Review 2.  Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.

Authors:  S F Yanuck; J Pizzorno; H Messier; K N Fitzgerald
Journal:  Integr Med (Encinitas)       Date:  2020

Review 3.  Misconstrued versatility of Ganoderma lucidum: a key player in multi-targeted cellular signaling.

Authors:  Balraj Singh Gill; Prateek Sharma; Raj Kumar; Sanjeev Kumar
Journal:  Tumour Biol       Date:  2015-12-30

4.  Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota.

Authors:  Chih-Jung Chang; Chuan-Sheng Lin; Chia-Chen Lu; Jan Martel; Yun-Fei Ko; David M Ojcius; Shun-Fu Tseng; Tsung-Ru Wu; Yi-Yuan Margaret Chen; John D Young; Hsin-Chih Lai
Journal:  Nat Commun       Date:  2015-06-23       Impact factor: 14.919

Review 5.  Ganoderma: A Cancer Immunotherapy Review.

Authors:  Yu Cao; Xiaowei Xu; Shujing Liu; Linfang Huang; Jian Gu
Journal:  Front Pharmacol       Date:  2018-10-25       Impact factor: 5.810

6.  Effects of a natural nutritional supplement on immune cell infiltration and immune gene expression in exercise-induced injury.

Authors:  Feng Jiang; Rongfeng Yang; Diya Xue; Rong Li; Meiling Tan; Zhicong Zeng; Luhua Xu; Linling Liu; Yinzhi Song; Fengxia Lin
Journal:  Front Nutr       Date:  2022-09-16

7.  Effects of total flavonoids of sea buckthorn ( Hippophae rhamnoides L.) on cytotoxicity of NK92-MI cells.

Authors:  Diandong Hou; Decheng Wang; Xiande Ma; Wenna Chen; Shengnan Guo; Hongquan Guan
Journal:  Int J Immunopathol Pharmacol       Date:  2017-10-10       Impact factor: 3.219

8.  Antitumor Activity of Extract From the Sporoderm-Breaking Spore of Ganoderma lucidum: Restoration on Exhausted Cytotoxic T Cell With Gut Microbiota Remodeling.

Authors:  Jiyan Su; Lu Su; Dan Li; Ou Shuai; Yifan Zhang; Huijia Liang; Chunwei Jiao; Zhanchi Xu; Yong Lai; Yizhen Xie
Journal:  Front Immunol       Date:  2018-07-31       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.